Deerfield Management Company, L.P. (Series C) Viatris Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Viatris Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 24,099,083 shares of VTRS stock, worth $258 Million. This represents 4.44% of its overall portfolio holdings.
Number of Shares
24,099,083
Previous 24,023,907
0.31%
Holding current value
$258 Million
Previous $215 Million
11.21%
% of portfolio
4.44%
Previous 4.93%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,137Shares Held
966MCall Options Held
7.74MPut Options Held
2.47M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...